Inventor
GOSLING JENNIFA
US13 patents
⚠️ This page may combine multiple inventors who share the name “GOSLING JENNIFA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NURIX THERAPEUTICS INC
9 patentsUS11530229B2Dec 20, 2022
Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
NURIX THERAPEUTICS INC12 citations84
US11464802B2Oct 11, 2022
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
NURIX THERAPEUTICS INC14 citations84
US11401267B2Aug 2, 2022
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
NURIX THERAPEUTICS INC11 citations84
US11951133B2Apr 9, 2024
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
NURIX THERAPEUTICS INC2 citations71
US12485144B2Dec 2, 2025
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
NURIX THERAPEUTICS INC1 citations62
US12234230B2Feb 25, 2025
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
NURIX THERAPEUTICS INC1 citations62
US12049471B2Jul 30, 2024
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof
NURIX THERAPEUTICS INC1 citations61
US12121540B2Oct 22, 2024
CBL inhibitors and compositions for use in adoptive cell therapy
NURIX THERAPEUTICS INC1 citations57
US12594263B2Apr 7, 2026
CBL inhibitors and compositions for expansion of immune cells
NURIX THERAPEUTICS INC0 citations53
CHEMOCENTRYX INC
4 patentsUS6998239B1Feb 14, 2006
Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
CHEMOCENTRYX INC12 citations83
US6835547B1Dec 28, 2004
Methods for identifying modulators of CCX CKR activity
CHEMOCENTRYX INC7 citations71
US7108990B2Sep 19, 2006
Chemokine receptor
CHEMOCENTRYX INC0 citations51
USRE39849ESep 18, 2007
Methods for identifying modulators of CCX CKR activity
CHEMOCENTRYX INC0 citations41